Philips empowers Indian interventionalists with the introduction of world-class new Azurion

Additionally, Philips is maximizing the uptime of its angio suite solutions by using AI and machine learning to monitor system performance through the new remote connection services of the Philips Service Hub. These services communicate, monitor, and proactively respond to potential service issues in advance so that pre-emptive action can be taken.

The new Azurion, set-up at Philips Innovation Campus, Bengaluru - the company’s largest innovation hub globally - was showcased to 80 interventionalists from across India. “At Philips India, we are committed to advancing health technology to improve lives and healthcare outcomes across the country. The new Azurion, empowers our customers to transform how patients are treated for a broad range of critical illnesses, including cardiovascular and neurovascular diseases. Philips, through its significant investments, is committed in developing a world class healthcare ecosystem in India by way of R&D, software, services and manufacturing,” said Bharath Sesha, Managing Director, Philips Indian Subcontinent.

The new Azurion system brings state of the art imaging capabilities and flexible ergonomic gantry positioning to optimize clinician workflow, ensuring faster and more precise treatment for the patients. This focus on enhanced imaging and efficiency reflects Philips’ commitment to improving patient outcomes in India. By allowing interventionalists to treat more patients, more efficiently, with potentially better outcomes, the Philips new Azurion enhances both the staff and patient experience and contributes to lower cost of care.

“Philips Innovation Campus has been evolving steadily and I can confidently state that today we are seen as drivers of end-to-end innovation value chain. This implies that we have been able to collectively work towards value creation for our businesses globally, harnessing our well-established software capabilities along with deep Artificial Intelligence in healthcare domain. Further, being a microcosm of Philips global business helps us to accelerate innovations by leveraging our cross-businesses and cross-functional teams within and co-create with teams outside of India as well. The new Azurion system is an outcome of such a collaborative effort. Our teams are also continuously engaging with healthcare leaders and technicians to develop solutions that can address the unique healthcare challenges in India and around the world,” said Arvind Vaishnav, Head, Philips Innovation Campus and Innovation Partnerships – Growth region, Philips.

“It was interesting to see innovative solutions at Philips recently. I am particularly looking forward to the potentially game-changing Direct-to-Angio-Suite (DTAS) feature. This innovative technology will revolutionize stroke care by significantly reducing door-to-puncture time, thereby, improving patient outcomes and saving lives. The new Azurion evidently has advanced capabilities and will enable the interventionalist to provide more efficient and effective treatment, enhancing the quality of life of patients,” said Dr. Santhosh Joseph, Senior Consultant & Clinical Lead, Neuro Interventional, KIMSHEALTH, Trivandrum.

"As an interventionalist, it gives me immense delight to see technologies evolving so rapidly especially in treating percutaneous coronary interventions or what is generally termed as narrowing of heart arteries. Technologies developed by Philips in this space, which many of us recently experienced, can potentially help interventionalists like us to dramatically decrease contrast and optimize radiation dose administration during the procedure ensuring both the safety and quality of PCI,” said Dr. T.S. Kler, Chairman & HOD, BLK-Max Heart & Vascular Institute, BLK-Max Super Speciality Hospital, Delhi.